Form 4 for ARMP Armata Pharmaceuticals, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001567619-22-003750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-02-11 | 2022-02-09 | ARMP | Innoviva Strategic Opportunities LLC | Dir, 10% | P - Purchase | $5.00 | +3.61M | 10.98M | +49% | +$18.07M |
| DI | 2022-02-11 | 2022-02-09 | ARMP | Innoviva Strategic Opportunities LLC | Dir, 10% | P - Purchase | $5.00 | +1.81M | 1.81M | New | +$9.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | P | A | 3,614,792 | $5.00 | 10,980,761 | I See footnotes | — | — | (F1) See Exhibit 99.1 (F2) See Exhibit 99.1 |
| 2 | Derivative | Warrants to Purchase Common Stock | 2022-02-09 | P | A | 1,807,396 | $5.00 | 1,807,396 | I See footnotes | $5.00 · 2022-02-09 to 2027-02-09 | 1,807,396 Common Stock | (F1) See Exhibit 99.1 (F2) See Exhibit 99.1 |